3D breast tomosynthesis segment is expected to grow at highest CAGR in the next five years, owing to increasing regulatory approvals for 3D breast tomosythesis systems, benefits offered by these systems over other technologies, and higher patient accessibility offered by these systems.

Hologic, Inc. (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Gamma Medica, Inc. (U.S.), Toshiba Corporation (Japan), Sonocine, Inc. (U.S.), Aurora Imaging Technology, Inc. (U.S.), and Dilon Technologies, Inc. (U.S.) are some of key players operating in global breast imaging market.


Click now for more information on this research of “Breast Imaging Market by Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM) Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) - Forecast to 2021” report @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=68046 .

Report will enrich both established firms and new entrants/smaller firms to gauge pulse of market, which in turn will help firms in garnering a greater market share. Firms purchasing report could use any one or combination of below-mentioned five strategies (market penetration, product development/innovation, breast imaging market development, market diversification, and competitive assessment) for strengthening their market shares.

Emerging countries, including China and India, are expected to offer significant growth opportunities to market players in coming years. Growth in these markets will majorly be driven by rising incidence of breast cancer and significant investments by governments and leading players in emerging countries.

Explore more reports on Medical Imaging at http://www.rnrmarketresearch.com/reports/life-sciences/diagnostics/medical-imaging .

Back to HCB News

Market Analysis Homepage